Avient (AVNT) Q4 2010 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2010 earnings summary
10 Nov, 2026Executive summary
FY2010 sales rose 27.2% to $2,621.9M as volume recovered across end markets; operating income reached $174.3M and net income was $162.6M, including significant one-time gains and tax benefits.
Q4 sales were $617.8M, operating income $37.1M and net income $97.5M; quarterly results included a $90.3M tax benefit and a $16.3M BayOne sale gain.
Recovery and Lean Six Sigma savings lifted results, while raw-material inflation, slower building/construction recovery and lower caustic soda prices remained key considerations.
Financial highlights
FY2010 sales rose $561.2M, or 27.2%, to $2,621.9M; volumes increased 18.2%, with higher market pricing reflecting ~9% raw-material inflation.
Gross margin increased to $428.9M from $322.2M; cost of sales declined to 83.6% of sales from 84.4%, aided by savings and legal/insurance settlement gains.
Operating income increased 117.6% to $174.3M; net income was $162.6M versus $49.5M, with 2010 including $23.9M settlement gains, a $16.3M BayOne gain, $29.5M debt-extinguishment costs and a $107.1M tax valuation-allowance reversal.
Operating cash flow was $140.8M versus $229.7M; year-end cash was $378.1M and total liquidity was $506.3M.
Outlook and guidance
2011 priorities: top-line growth, improved cost/price recovery for raw materials, working-capital efficiency, and margin-improvement targets across businesses.
2011 capital expenditures estimated at $40M, primarily for sales growth, information-system integration and strategic investments; R&D spending expected to increase moderately.
Expected 2011 pension contributions were $24.8M; environmental remediation cash outlays were expected to be $15M.
Available capital resources and operating cash flow were expected to cover 2011 operating needs, debt service and minimum pension funding requirements.
Latest events from Avient
- FY06 earnings rebounded, but 2007 margin gains faced soft demand and chlorovinyl headwinds.AVNT
Q4 2006 - Debt fell after the OxyVinyls sale, but weak construction and remediation charges depressed 2007 earnings.AVNT
Q4 2007 - Late-year demand collapse and large one-time charges turned modest sales growth into a $272.9M loss.AVNT
Q4 2008 - Operating income recovered to $98.4M as cash strengthened despite a 24.8% sales decline.AVNT
Q4 2009 - FY11 growth met a pension-driven Q4 operating loss and major portfolio changes.AVNT
Q4 2011 - Record adjusted EPS and a specialty-led mix shift offset soft markets and lower reported earnings.AVNT
Q4 2012 - Acquisitions drove FY13 growth, alongside a major divestiture gain and integration costs.AVNT
Q4 2013 - Record adjusted EPS and stronger specialty mix offset restructuring and pension charges.AVNT
Q4 2014 - Adjusted EPS rose 9%, as specialty growth offset revenue and DSS headwinds.AVNT
Q4 2015